Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 2000 Sep-Oct;6(5):530–533. doi: 10.3201/eid0605.000513

Prevalence of non-O157:H7 shiga toxin-producing Escherichia coli in diarrheal stool samples from Nebraska.

P D Fey 1, R S Wickert 1, M E Rupp 1, T J Safranek 1, S H Hinrichs 1
PMCID: PMC2627960  PMID: 10998385

Abstract

We determined the prevalence of Shiga toxin-producing Escherichia coli (STEC) in diarrheal stool samples from Nebraska by three methods: cefixime-tellurite sorbitol MacConkey (CT- SMAC) culture, enterohemorrhagic E. coli (EHEC) enzyme immunoassay, and stx1,2 polymerase chain reaction (PCR). Fourteen (4.2%) of 335 specimens were positive by at least one method (CT-SMAC culture [6 of 14], EHEC enzyme immunoassay [13 of 14], stx1,2 PCR [14 of 14]). Six contained serogroup O157, while non-O157 were as prevalent as O157 serogroups.

Full Text

The Full Text of this article is available as a PDF (29.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beutin L., Zimmermann S., Gleier K. Human infections with Shiga toxin-producing Escherichia coli other than serogroup O157 in Germany. Emerg Infect Dis. 1998 Oct-Dec;4(4):635–639. doi: 10.3201/eid0404.980415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Boerlin P., Chen S., Colbourne J. K., Johnson R., De Grandis S., Gyles C. Evolution of enterohemorrhagic Escherichia coli hemolysin plasmids and the locus for enterocyte effacement in shiga toxin-producing E. coli. Infect Immun. 1998 Jun;66(6):2553–2561. doi: 10.1128/iai.66.6.2553-2561.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Boerlin P., McEwen S. A., Boerlin-Petzold F., Wilson J. B., Johnson R. P., Gyles C. L. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol. 1999 Mar;37(3):497–503. doi: 10.1128/jcm.37.3.497-503.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Boudailliez B., Berquin P., Mariani-Kurkdjian P., Ilef D., Cuvelier B., Capek I., Tribout B., Bingen E., Piussan C. Possible person-to-person transmission of Escherichia coli O111--associated hemolytic uremic syndrome. Pediatr Nephrol. 1997 Feb;11(1):36–39. doi: 10.1007/s004670050229. [DOI] [PubMed] [Google Scholar]
  5. Caprioli A., Luzzi I., Rosmini F., Resti C., Edefonti A., Perfumo F., Farina C., Goglio A., Gianviti A., Rizzoni G. Community-wide outbreak of hemolytic-uremic syndrome associated with non-O157 verocytotoxin-producing Escherichia coli. J Infect Dis. 1994 Jan;169(1):208–211. doi: 10.1093/infdis/169.1.208. [DOI] [PubMed] [Google Scholar]
  6. Fagan P. K., Hornitzky M. A., Bettelheim K. A., Djordjevic S. P. Detection of shiga-like toxin (stx1 and stx2), intimin (eaeA), and enterohemorrhagic Escherichia coli (EHEC) hemolysin (EHEC hlyA) genes in animal feces by multiplex PCR. Appl Environ Microbiol. 1999 Feb;65(2):868–872. doi: 10.1128/aem.65.2.868-872.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fratamico P. M., Sackitey S. K., Wiedmann M., Deng M. Y. Detection of Escherichia coli O157:H7 by multiplex PCR. J Clin Microbiol. 1995 Aug;33(8):2188–2191. doi: 10.1128/jcm.33.8.2188-2191.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gautom R. K. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol. 1997 Nov;35(11):2977–2980. doi: 10.1128/jcm.35.11.2977-2980.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kaplan B. S., Cleary T. G., Obrig T. G. Recent advances in understanding the pathogenesis of the hemolytic uremic syndromes. Pediatr Nephrol. 1990 May;4(3):276–283. doi: 10.1007/BF00857676. [DOI] [PubMed] [Google Scholar]
  10. Karmali M. A., Petric M., Lim C., Fleming P. C., Arbus G. S., Lior H. The association between idiopathic hemolytic uremic syndrome and infection by verotoxin-producing Escherichia coli. J Infect Dis. 1985 May;151(5):775–782. doi: 10.1093/infdis/151.5.775. [DOI] [PubMed] [Google Scholar]
  11. Kudva I. T., Hatfield P. G., Hovde C. J. Characterization of Escherichia coli O157:H7 and other Shiga toxin-producing E. coli serotypes isolated from sheep. J Clin Microbiol. 1997 Apr;35(4):892–899. doi: 10.1128/jcm.35.4.892-899.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. McDaniel T. K., Kaper J. B. A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. Mol Microbiol. 1997 Jan;23(2):399–407. doi: 10.1046/j.1365-2958.1997.2311591.x. [DOI] [PubMed] [Google Scholar]
  13. Paton A. W., Woodrow M. C., Doyle R. M., Lanser J. A., Paton J. C. Molecular characterization of a Shiga toxigenic Escherichia coli O113:H21 strain lacking eae responsible for a cluster of cases of hemolytic-uremic syndrome. J Clin Microbiol. 1999 Oct;37(10):3357–3361. doi: 10.1128/jcm.37.10.3357-3361.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Slutsker L., Ries A. A., Greene K. D., Wells J. G., Hutwagner L., Griffin P. M. Escherichia coli O157:H7 diarrhea in the United States: clinical and epidemiologic features. Ann Intern Med. 1997 Apr 1;126(7):505–513. doi: 10.7326/0003-4819-126-7-199704010-00002. [DOI] [PubMed] [Google Scholar]
  15. Slutsker L., Ries A. A., Maloney K., Wells J. G., Greene K. D., Griffin P. M. A nationwide case-control study of Escherichia coli O157:H7 infection in the United States. J Infect Dis. 1998 Apr;177(4):962–966. doi: 10.1086/515258. [DOI] [PubMed] [Google Scholar]
  16. Srámková L., Bielaszewská M., Janda J., Bláhova K., Hausner O. Vero cytotoxin-producing strains of Escherichia coli in children with haemolytic uraemic syndrome and diarrhoea in Czechoslovakia. Infection. 1990 Jul-Aug;18(4):204–209. doi: 10.1007/BF01643386. [DOI] [PubMed] [Google Scholar]
  17. Stephan R., Untermann F. Virulence factors and phenotypical traits of verotoxin-producing Escherichia coli strains isolated from asymptomatic human carriers. J Clin Microbiol. 1999 May;37(5):1570–1572. doi: 10.1128/jcm.37.5.1570-1572.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Tarr P. I., Fouser L. S., Stapleton A. E., Wilson R. A., Kim H. H., Vary J. C., Jr, Clausen C. R. Hemolytic-uremic syndrome in a six-year-old girl after a urinary tract infection with Shiga-toxin-producing Escherichia coli O103:H2. N Engl J Med. 1996 Aug 29;335(9):635–638. doi: 10.1056/NEJM199608293350905. [DOI] [PubMed] [Google Scholar]
  19. Zadik P. M., Chapman P. A., Siddons C. A. Use of tellurite for the selection of verocytotoxigenic Escherichia coli O157. J Med Microbiol. 1993 Aug;39(2):155–158. doi: 10.1099/00222615-39-2-155. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES